U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H25NO
Molecular Weight 271.3972
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOMETHORPHAN

SMILES

COC1=CC=C2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)C2=C1

InChI

InChIKey=MKXZASYAUGDDCJ-CGTJXYLNSA-N
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H25NO
Molecular Weight 271.3972
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26226106 | https://www.ncbi.nlm.nih.gov/pubmed/23628523 | https://www.ncbi.nlm.nih.gov/pubmed/24142584

Racemethorphan is racemic mixture of Dextromethorphan and Levomethorphan. Racemethorphan is listed under the Single Convention on Narcotic Drugs 1961 and is therefore listed in the United States as a Controlled Substance, specifically as a Narcotic in Schedule II. Dextromethorphan is a non-narcotic morphine derivative widely used as an antitussive. Dextromethorphan is a cough suppressant in many over-the-counter cold and cough medicines. In 2010, the FDA approved the combination product dextromethorphan/quinidine for the treatment of pseudobulbar affect. Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Levomethorphan is an opioid analgesic of the morphinan family that has never been marketed.

CNS Activity

Curator's Comment: https://www.ncbi.nlm.nih.gov/pubmed/16634036

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Over-the-counter medications for acute cough in children and adults in ambulatory settings.
2001
Dystonia as acute adverse reaction to cough suppressant in a 3-year-old girl.
2001
The placebo response to citric acid-induced cough: pharmacodynamics and gender differences.
2001
Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain.
2001 Aug
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
2001 Aug
Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California.
2001 Aug
A fast and efficient determination of amines and preservatives in cough and cold liquid and suspension formulations using a single isocratic ion-pairing high performance [correction of power] liquid chromatography method.
2001 Aug
Dextromethorphan increases tyrosine hydroxylase mRNA in the mesencephalon of adolescent rats.
2001 Aug 24
The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.
2001 Dec
CYP2D6 polymorphism in a Mexican American population.
2001 Dec
Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
2001 Dec 1
Improved postoperative pain control in pediatric adenotonsillectomy with dextromethorphan.
2001 Jul
Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
2001 Jul
NMDA receptor-mediated modulation of ventilation in obese Zucker rats.
2001 Jul
Combined pre-incisional oral dextromethorphan and epidural lidocaine for postoperative pain reduction and morphine sparing: a randomised double-blind study on day-surgery patients.
2001 Jul
Increasing bioanalytical throughput using pcSFC-MS/MS: 10 minutes per 96-well plate.
2001 Jul 1
Cold-syrup induced movement disorder.
2001 Jun
Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats.
2001 Jun 22
Dextromethorphan affects cocaine-mediated behavioral pattern in parallel with a long-lasting Fos-related antigen-immunoreactivity.
2001 Jun 29
Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine.
2001 Jun 29
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats.
2001 Jun 29
Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers.
2001 May
Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
2001 Nov
Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats.
2001 Nov 5
Effects of dextromethorphan on nocturnal behavior and brain c-Fos expression in adolescent rats.
2001 Nov 9
St. John's wort: effect on CYP2D6 activity using dextromethorphan-dextrorphan ratios.
2001 Oct
Dextromethorphan in pregnancy.
2001 Sep
The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites.
2002
Analgesic effects of dextromethorphan and morphine in patients with chronic pain.
2002 Apr
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
2002 Apr
Modulation of human corticomotor excitability by somatosensory input.
2002 Apr 15
Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers.
2002 Feb
Development of a rapid and sensitive high-performance liquid chromatographic method to determine CYP2D6 phenotype in human liver microsomes.
2002 Feb
Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys.
2002 Feb
The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.
2002 Jan
Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.
2002 Jan
Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia.
2002 Jan
Dextromethorphan can produce false positive phencyclidine testing with HPLC.
2002 Jan
Inhibition kinetics of monoclonal antibodies against cytochromes P450.
2002 Jun
Treatment of codeine dependence with inhibitors of cytochrome P450 2D6.
2002 Jun
Is glutamate involved in transient lower esophageal sphincter relaxations?
2002 Mar
CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity.
2002 Mar
Selective suppression of late laryngeal adductor responses by N-methyl-D-aspartate receptor blockade in the cat.
2002 Mar
Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
2002 Mar 1
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.
2002 Mar 1
The effects of concomitant administration of theophylline and toborinone on the pharmacokinetics of both compounds in poor and extensive metabolizers via CYP2D6.
2002 May
Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
2002 May
Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
2002 May
Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial.
2002 May 11
Semi-automated liquid--liquid back-extraction in a 96-well format to decrease sample preparation time for the determination of dextromethorphan and dextrorphan in human plasma.
2002 May 25
Patents

Sample Use Guides

Levomethorphan (dissolved in a mixed solution of 5% Emulphor™ EL-620/5% ethanol/90% isotonic sodium chloride solution, 2.5 mg/mL, rat 4–6) was administered to male DA pigmented rats, which were 5 weeks old and around 90 g mean weight. The drugs were given once daily at 5 mg/kg by intraperitoneal injection for ten successive days.
Route of Administration: Intraperitoneal
Liver microsomes from individual male dark agouti (DA) rats (n=4, 6 weeks old, around 125 g mean weight) were prepared by ultracentrifugation. For the in vitro experiments with rat and human liver microsomes, the reaction mixture consisted of 0.1 M potassium phosphate buffer (pH 7.4) with an NADPH generating system (1.3 mM NADP, 3.3 mM G-6-P, 0.4 U/ mL G-6-PDH, 3.3 mM MgCl2), 50 μM substrate (dextromethorphan or levomethorphan), and 0.5 mg protein/mL microsomes (rat or human liver microsomes) in a final volume of 200 μL. Dextromethorphan and levomethorphan were dissolved in methanol, and the final concentration of the organic solvent was 0.1%. The incubation was started by adding the microsomal fraction and then continued for 0, 5, 10, or 20 min. The reaction was terminated by adding an equal volume of a mixed organic solution of 50% acetonitrile and 50% methanol, including 10 μM levallorphan (IS), and vigorous shaking.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:19:11 GMT 2025
Edited
by admin
on Mon Mar 31 18:19:11 GMT 2025
Record UNII
7ZZ22K9QE6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEVOMETHORPHAN
INN   MI  
INN  
Official Name English
IDS-NL-004
Preferred Name English
LEVOMETHORPHAN [MI]
Common Name English
levomethorphan [INN]
Common Name English
L-METHORPHAN
Common Name English
LEVOMETHORPHAN SOLUTION [USP-RS]
Common Name English
(-)-3-METHOXY-N-METHYLMORPHINAN
Systematic Name English
2H-10,4A-IMINOETHANOPHENANTHRENE, 1,3,4,9,10,10A-HEXAHYDRO-6-METHOXY-11-METHYL-
Systematic Name English
IDS-NL-005
Code English
MORPHINAN, 3-METHOXY-17-METHYL-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C67413
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
DEA NO. 9210
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
Code System Code Type Description
EVMPD
SUB08478MIG
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
WIKIPEDIA
LEVOMETHORPHAN
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
INN
148
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
CHEBI
146176
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
NCI_THESAURUS
C83875
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
ECHA (EC/EINECS)
204-751-7
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
EPA CompTox
DTXSID20872403
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
FDA UNII
7ZZ22K9QE6
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
ChEMBL
CHEMBL1908323
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
MERCK INDEX
m6790
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY Merck Index
SMS_ID
100000082278
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
CAS
125-70-2
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
PUBCHEM
5362449
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
RS_ITEM_NUM
1362359
Created by admin on Mon Mar 31 18:19:11 GMT 2025 , Edited by admin on Mon Mar 31 18:19:11 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
Related Record Type Details
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY